The meeting brings together the leading scientists and clinicians from across the world in the field of transplantation for type 1 diabetes (both solid organ pancreas transplantation and islet cell transplantation). State-of-the-art advances are being discussed, including stem cell transplantation and implantable devices that could end the end for anti-rejection medication with islet cell transplants.
Professor Paul Johnson, the Chair of the Local Organising Committee (IPITA 2017), said: ‘It is a great privilege to have been entrusted with hosting the IPITA 2017 Congress in Oxford. The UK has a strong track record in the fields of whole pancreas and islet transplantation and has been instrumental in a number of key developments including being one of the first countries in the world to have a nationally commissioned clinical islet transplant programme, as well as establishing the first joint whole organ and islet donor pancreas allocation scheme.’
The Congress is being held at the Mathematics Institute in Oxford with over 400 delegates and is a partnership between NDS and IPITA.